EUVIMEDEUVIMED entdecken
Crossref

Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review

Jaykumar G. Parmar, Yagnesh M. Dalvadi

International Journal of Global Business and Competitiveness · 2026-09 · 21 (2) · 146-155

DOI: 10.1007/s42943-026-00159-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Global Business and Competitiveness, online erschienen am 26.08.2026. Verfasst von Jaykumar G. Parmar und 1 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Parmar, J. G., & Dalvadi, Y. M. (2026). Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review. International Journal of Global Business and Competitiveness, 21(2), 146-155. https://doi.org/10.1007/s42943-026-00159-8

Vancouver

Parmar JG, Dalvadi YM. Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review. International Journal of Global Business and Competitiveness. 2026;21(2):146-155. doi:10.1007/s42943-026-00159-8

BibTeX
@article{Parmar2026,
  author = {Parmar, Jaykumar G. and Dalvadi, Yagnesh M.},
  title = {Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review},
  journal = {International Journal of Global Business and Competitiveness},
  year = {2026},
  volume = {21},
  number = {2},
  pages = {146--155},
  doi = {10.1007/s42943-026-00159-8}
}
Kostenlos starten →